Tiziana Life Sciences Ltd
TLSA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $3 | $3 | $5 | $5 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6 | $6 | $8 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9 | $9 | $13 | $6 |
| Operating Income | -$9 | -$9 | -$13 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3 | $0 | -$3 | -$2 |
| Pre-Tax Income | -$6 | -$9 | -$16 | -$9 |
| Tax Expense | $0 | -$2 | -$7 | $0 |
| Net Income | -$6 | -$7 | -$9 | -$9 |
| % Margin | – | – | – | – |
| EPS | -0.096 | -0.13 | -0.18 | -0.18 |
| % Growth | 25.8% | 27.8% | 0% | – |
| EPS Diluted | -0.096 | -0.13 | -0.18 | -0.18 |
| Weighted Avg Shares Out | 58 | 55 | 52 | 51 |
| Weighted Avg Shares Out Dil | 58 | 55 | 52 | 51 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $0 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$6 | -$9 | -$16 | -$9 |
| % Margin | – | – | – | – |